Dashboard
Manage Tickers

BMYBRISTOL MYERS SQUIBB CO

NYSE bms.com


$ 42.35 $ 0.07 (0.17 %)    

Wednesday, 22-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 0.11 (0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -0.24 (-0.11 %)
$ 42.34
$ 42.09
$ 0.00 x 0
$ 0.00 x 0
$ 41.92 - $ 42.98
$ 41.91 - $ 64.39
16,786,014
na
85.83B
$ 0.53
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-13-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 02-25-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-13-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 10-24-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bristol-myers-squibb-to-present-karxt-data-at-ascp-may-28-31
Bristol Myers Squibb To Present KarXT Data...
05/23/2024 11:01:35

hawaii-court-rules-against-bristol-myers-sanofi-in-blood-clot-drug-case-increases-liability-to-916m
Hawaii Court Rules Against Bristol Myers, ...
05/22/2024 17:25:12

A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the hea...

bristol-myers-squibb-announced-aspire-a-10-year-strategy-with-an-aim-to-reach-over-200000-patients-in-low-and-middle-income-countries-by-2033-as-part-of-aspire-bristol-myers-is-developing-tailored-strategies-to-increase-affordability-and-availability
Bristol Myers Squibb Announced Aspire, A 1...
05/22/2024 11:08:56

spotlight-on-bristol-myers-squibb-analyzing-the-surge-in-options-activity
Spotlight on Bristol-Myers Squibb: Analyzi...
05/21/2024 15:45:56

the-fda-has-reassigned-prescription-drug-user-fee-act-date-for-bristol-myers-squibbs-subcutaneous-formulation-of-opdivo-nivolumab-across-all-previously-approved-adult-solid-tumor-opdivo-indications-the-updated-goal-date-is-december-29
The FDA Has Reassigned Prescription Drug U...
05/21/2024 11:01:55

abbvie-is-successfully-positioned-to-absorb-humira-biosimilar-erosion--analyst
AbbVie Is 'Successfully Positioned To Abso...
05/17/2024 17:47:16

Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humir...

Core News & Articles
On CNBC, Jason Snipe Announced Bought More...
05/17/2024 17:01:43

fda-approves-expanded-use-of-bristol-myers-squibbs-breyanzi-cancer-cell-therapy-for-previously-treated-follicular-lymphoma
FDA Approves Expanded Use Of Bristol Myers...
05/16/2024 15:56:18

FDA grants accelerated approval for Bristol Myers Squibb's Breyanzi, a CAR T cell therapy, for relapsed or refractory folli...

bristol-myers-squibb-presents-new-4-year-sotyktu-data-demonstrate-durable-response-rates-and-consistent-safety-in-moderate-to-severe-plaque-psoriasis
Bristol Myers Squibb Presents New 4-Year S...
05/16/2024 14:26:57

Following four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients fo...

fda-grants-accelerated-approval-to-bristol-myers-squibbs-lisocabtagene-maraleucel-for-follicular-lymphoma
FDA Grants Accelerated Approval To Bristol...
05/15/2024 20:59:09

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/14/2024 17:35:24

bristol-myers-squibb-shares-update-on-phase-3-checkmate--73l-trial-says-trial-did-not-meet-its-primary-endpoint-of-progression-free-survival-in-unresectable-locally-advanced-stage-iii-non-small-cell-lung-cancer
Bristol Myers Squibb Shares Update On Phas...
05/10/2024 20:32:53

Bristol Myers Squibb (NYSE:BMY) today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progressi...

whats-going-on-with-medical-therapeutic-firm-aethlon-medical-on-friday
What's Going On With Medical Therapeutic F...
05/10/2024 14:46:21

Aethlon Medical unveils results in removing extracellular vesicles (EVs) from plasma. Preclinical evidence supports upcoming ph...

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-with-over-5-dividend-yields
Wall Street's Most Accurate Analysts' View...
05/10/2024 12:01:24

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/09/2024 17:35:23

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/07/2024 17:35:23

top-4-health-care-stocks-which-could-rescue-your-portfolio-this-month
Top 4 Health Care Stocks Which Could Rescu...
05/07/2024 11:18:46

european-medicines-agency-validates-type-2-variation-application-for-bristol-myers-squibbs-opdivo-nivolumab-plus-yervoy-ipilimumab-for-first-line-treatment-of-microsatellite-instabilityhigh-or-mismatch-repair-deficient-metastatic-colorectal-cancer
European Medicines Agency Validates Type 2...
05/06/2024 11:08:06

fda-bristol-myers-squibbs-application-for-subcutaneous-nivolumab-nivolumab-and-hyaluronidase-with-prescription-drug-user-fee-act-goal-date-of-february-28-2025
FDA Bristol Myers Squibb's Application For...
05/06/2024 11:01:45

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/03/2024 17:35:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION